Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840

NCT04422431 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Wilson Disease

Interventions

DRUG: Bis-Choline Tetrathiomolybdate

Sponsor

Alexion Pharmaceuticals, Inc.